Global Blood-based Biomarker Market Growth (Status and Outlook) 2025-2031
Description
The global Blood-based Biomarker market size is predicted to grow from US$ 1971 million in 2025 to US$ 3635 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.
A blood-based biomarker is a measurable biological molecule found in the blood that indicates normal or pathological processes in the body. These biomarkers can be proteins, nucleic acids, metabolites, or even circulating tumor cells that help diagnose diseases, monitor treatment responses, and predict patient outcomes. Blood-based biomarkers are widely used in oncology, neurology, and cardiovascular diseases, enabling early detection and personalized medicine approaches. Their non-invasive nature makes them highly valuable for routine clinical practice and research.
United States market for Blood-based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Blood-based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Blood-based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Blood-based Biomarker players cover Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Blood-based Biomarker Industry Forecast” looks at past sales and reviews total world Blood-based Biomarker sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood-based Biomarker sales for 2025 through 2031. With Blood-based Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood-based Biomarker industry.
This Insight Report provides a comprehensive analysis of the global Blood-based Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood-based Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood-based Biomarker market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood-based Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood-based Biomarker.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood-based Biomarker market by product type, application, key players and key regions and countries.
Segmentation by Type:
Next Generation Sequencing
Mass Spectrometry
Liquid Biopsy Technologies
Segmentation by Application:
Hospital
Diagnostic Centers
Research Labs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abbott
Siemens Healthineers
Danaher
Quidel Corporation
Grifols
Biocartis
Vernalis
Labcorp Drug Development
Please note: The report will take approximately 2 business days to prepare and deliver.
A blood-based biomarker is a measurable biological molecule found in the blood that indicates normal or pathological processes in the body. These biomarkers can be proteins, nucleic acids, metabolites, or even circulating tumor cells that help diagnose diseases, monitor treatment responses, and predict patient outcomes. Blood-based biomarkers are widely used in oncology, neurology, and cardiovascular diseases, enabling early detection and personalized medicine approaches. Their non-invasive nature makes them highly valuable for routine clinical practice and research.
United States market for Blood-based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Blood-based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Blood-based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Blood-based Biomarker players cover Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Blood-based Biomarker Industry Forecast” looks at past sales and reviews total world Blood-based Biomarker sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood-based Biomarker sales for 2025 through 2031. With Blood-based Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood-based Biomarker industry.
This Insight Report provides a comprehensive analysis of the global Blood-based Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood-based Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood-based Biomarker market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood-based Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood-based Biomarker.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood-based Biomarker market by product type, application, key players and key regions and countries.
Segmentation by Type:
Next Generation Sequencing
Mass Spectrometry
Liquid Biopsy Technologies
Segmentation by Application:
Hospital
Diagnostic Centers
Research Labs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abbott
Siemens Healthineers
Danaher
Quidel Corporation
Grifols
Biocartis
Vernalis
Labcorp Drug Development
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
106 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Blood-based Biomarker Market Size by Player
- 4 Blood-based Biomarker by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Blood-based Biomarker Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
